Donate Today
Your support ensures a brighter future for all Australians living with CF
Donate Now
Australasian CF Conference
Join us in Brisbane for the 15th Australasian CF Conference this August.
Register Now
Embracing Tomorrow
CF is the most common, life-limiting genetic condition affecting Australians.
Learn More
Previous slide
Next slide

Cystic Fibrosis Australia (CFA) is the peak consumer body for people living with cystic fibrosis (CF).

We focus on collaborative programmes and research, funding partnerships and advocacy.


CF is a recessive genetic condition. It primarily affects the lungs and digestive system because of a malfunction in the exocrine system, responsible for producing saliva, sweat, tears and mucus

Show your Support this end of financial year

Within 24hrs of his birth, Heath needed emergency surgery. 


It was at this point that his parents first heard the term ‘cystic fibrosis’. For three weeks, Heath remained in the neonatal intensive care unit (NICU), a period marked by tears, anxiety, and a sense of helplessness.

Get Involved

By supporting CFA you will be helping further research, development, collaboration and advocacy so that all Australians living with CF are represented at a national level and heard by Government and Health and Community sectors.

Numbers Speak

CF is a genetic condition, however, each person with CF is unique.


Australians live with CF

There are over

Gene mutations

Average life expectancy


A baby is born with CF every


CF Research

CFA leads the national research program, the Australian Cystic Fibrosis Research Trust (ACFRT), by overseeing all administration requirements. The ACFRT is dedicated to the core objective of funding research into the treatment and cure of CF.

It is important to note that 100% of the funds raised or donated to the ACFRT are used to support research. 

Standards of Care

The first four chapters of the Standards of Care For Cystic Fibrosis have been published, with more to be added in the coming months. 

Need More Information?

If you have any questions, need more information, or would like to sign up to our regular newsletters, please contact us. 

Scroll to Top